Last Week in GER Research: Tencent Backed IPOs, Niu, Innovent Biologics, Babytree and Fujifilm
Below is a recap of the key IPO and event-driven research produced by the Global Equity Research team. This week we highlight a very differentiated...
656 Views
Innovent Biologics (信达生物) IPO: Limited Upside Despite Strong Cornerstones (Part 3)
Innovent Biologics launched the institutional book building today and intends to raise USD 377 to USD 423 million, with an implied market...
411 Views
Innovent Biologics IPO Valuation: Surprisingly Grounded in Reality
Innovent Biologics Inc (1641475D HK) launched its Hong Kong IPO today. The mid-point of Innovent's IPO price range of HK$12.50-14.00 per share...
692 Views
Innovent Biologics (信达生物) IPO: Pricing the PD-1 and Biosimilars Competition (Part 2)
Innovent Biologics, a leading biologics company in China, is raising up to USD 500 million to list in Hong Kong. In our previous insight (link...
582 Views
Last Week in GER Research: Tencent Music Vs. Spotify, Ganfeng Lithium, Meituan, Weidai, and Innovent
Below is a recap of the key IPO research produced by the Global Equity Research team. This week we highlight why we think Tencent Music...
405 Views